The National Agency for Food and Drug Administration and Control has alerted the general public of information it received from the Rwandan Food and Drug Authority, of withdrawal of two batches of Unibrol; Aminosidine Sulphate USP 250mg.
NAFDAC stated the recall was due to the discovery of anomalies in consignments of the drug subject to spontaneous assessments on the drug from retail pharmacies.
According to NAFDAC it was discovered that the drugs have an inconsistent colour due which some tablets of the same blister were changing colours.
NAFDAC further stated that Unibrol is an antibiotic that is used to treat intestinal infections. The product is manufactured by UNIVERSAL Corporation Ltd based in Kenya, with batch number: 5806898 and 5806675
NAFDAC has therefore urged importers, distributors, retailers, healthcare providers and consumers to be cautious to avoid the importation, distribution, sale and use of the withdrawn batches of Unibrol.
In view of this NAFDAC has advised healthcare professionals and consumers to report adverse effects experienced from the use of the product to the nearest NAFDAC office.
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate